GleamWall
中文EN

ECIA ENCISION INC

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 930775 · Fiscal year ends 03/31

Financial factors as of 2025-09-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-3.0%
TTM net income YoY45.0%
TTM EPS YoY50.0%
Revenue 3-yr CAGR-5.3%
Net income 3-yr CAGR—

Margins

Gross margin52.6%
Operating margin-5.1%
Net margin-6.0%
FCF margin-8.6%
EBITDA margin-3.7%

Returns

ROE-21.4%
ROA-10.1%
ROIC (approx.)-15.5%
Asset turnover1.66x

Leverage & solvency

Liabilities / assets54.0%
Debt / equity0.00x
Current ratio2.28x
Interest coverage-5.69x

Cash quality & payout

Operating cash flow / net income1.29x
Accruals ratio2.9%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q22025-09-302026Q12025-06-302025Q4*2025-03-312025Q32024-12-312025Q22024-09-302025Q12024-06-302024Q4*2024-03-312024Q32023-12-31
Income statement
Revenue$1.53M$1.60M$1.58M$1.59M$1.76M$1.63M$1.52M$1.58M
Cost of revenue$830,717$724,269$693,564$735,291$926,906$688,268$841,155$854,325
Gross profit$697,333$878,459$889,852$850,290$828,482$942,663$683,389$727,239
R&D expense$201,392$165,440$159,652$138,804$155,515$139,180$201,543$151,077
SG&A expense$358,639$328,198$320,104$355,200$373,405$351,903$414,024$351,569
Operating income-$258,491-$19,780-$20,537-$20,867-$158,918$28,343-$329,532-$189,399
Interest expense$11,384$18,009$17,248$9,508$10,598$6,369$10,225$21,065
Pretax income-$267,833-$41,133-$47,308-$24,668-$170,262$22,041-$336,671-$207,130
Income tax$0$0$0$0$0$0$0$0
Net income-$267,833-$41,133-$47,308-$24,668-$170,262$22,041-$336,671-$207,130
EBITDA-$232,698$2,997$3,001-$5,537-$135,715$47,665-$308,671-$168,817
EPS (basic)-0.020.00—0.00-0.010.00—-0.02
EPS (diluted)-0.020.00—0.00-0.010.00—-0.02
Weighted avg. shares (diluted)14.19M11.88M—11.88M11.88M11.88M—11.77M
Balance sheet
Cash & equivalents$71,731$47,918$257,433$347,919$230,014$270,444$42,509$99,239
Receivables$761,947$749,426$786,471$779,900$817,002$816,149$891,129$923,112
Inventory$1.47M$1.53M$1.48M$1.36M$1.16M$1.32M$1.40M$1.55M
Current assets$2.45M$2.45M$2.61M$2.69M$2.28M$2.51M$2.43M$2.71M
PP&E, net$250,016$233,847$244,757$269,768$266,125$251,760$254,004$268,715
Intangibles$161,427$166,708$171,890$175,233$169,283$166,473$164,010$165,567
Total assets$4.06M$4.13M$3.67M$3.86M$3.52M$3.82M$3.81M$4.29M
Current liabilities$1.07M$1.28M$1.58M$1.61M$1.14M$1.19M$1.07M$1.06M
Total liabilities$2.19M$2.51M$2.02M$2.17M$1.82M$1.96M$1.98M$2.09M
Shareholders' equity$1.86M$1.62M$1.65M$1.69M$1.70M$1.86M$1.83M$2.19M
Shares outstanding—11.88M11.88M11.88M11.88M11.88M11.86M11.77M
Cash flow statement
Operating cash flow-$126,641-$115,508-$201,802-$45,845$75,171$117,528-$10,963$158,355
Capital expenditure$36,680$6,535-$6,919$18,775$28,415$14,144-$1$11,929
Free cash flow-$163,321-$122,043-$194,883-$64,620$46,756$103,384-$10,962$146,426
Investing cash flow-$48,463-$6,685$4,818-$24,925-$40,377-$19,541-$4,595-$15,379
Financing cash flow$198,917-$87,322$106,498$188,675-$75,224$129,948-$41,172-$349,738
Depreciation & amortization$25,793$22,777$23,538$15,330$23,203$19,322$20,861$20,582
Stock-based compensation$10,532$12,119$12,475$9,964$12,637$12,374$39,379$27,158

Free plan shows the latest 8 periods; Pro shows all 62 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.